Literature DB >> 2036927

Results of the pelvic-pouch procedure in patients with Crohn's disease.

A A Deutsch1, R S McLeod, J Cullen, Z Cohen.   

Abstract

The pelvic-pouch procedure has become a standard operation for selected patients with ulcerative colitis, but is contraindicated in patients with Crohn's disease at our institution. However, the distinction between ulcerative colitis and Crohn's colitis can sometimes be difficult, if not impossible. Between January 1982, and March 1989, 272 patients with ulcerative colitis underwent pelvic-pouch procedures at our institution. Nine (3.5 percent) of these patients eventually were found to have Crohn's disease. The records of these patients were examined to assess their clinical outcome and complication rate. There were five females and four males with a mean age of 28.8 years. In five patients (Group I) the diagnosis of Crohn's disease was made postoperatively on histologic examination of the rectum. The ileostomy was closed in all patients. Two developed complications necessitating excision of the pouch. Three patients are well. In the other four cases (Group II) the mean time to diagnosis was 2.5 years after the pouch procedure. Three patients developed pouch-vaginal fistula, and one multiple anal fissures and stenosis. Two required excision of the pouch whereas two have a functioning pouch but with a persistent pouch-vaginal fistula (n = 1) or anal fissures (n = 1). Overall, four patients have had their pouches removed, and five patients have functioning pouches: three with no complications and two with persistent perianal disease. Thus, we would conclude that the pelvic-pouch procedure should not knowingly be performed in patients with Crohn's disease because of the high associated complication rate.

Entities:  

Mesh:

Year:  1991        PMID: 2036927     DOI: 10.1007/bf02049932

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  29 in total

1.  Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.

Authors:  M Farmer; L Hunt; M R Eichenberger; R E Petras; J E Janosky; S Galandiuk
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 2.  The role of pathology in pelvic ileal reservoir surgery.

Authors:  B F Warren; N A Shepherd
Journal:  Int J Colorectal Dis       Date:  1992-06       Impact factor: 2.571

3.  Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis.

Authors:  Bo Shen; Bret Lashner
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

Review 4.  Indeterminate colitis.

Authors:  P J Mitchell; M Y Rabau; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-05-25       Impact factor: 3.781

5.  Restorative operations for Crohn's disease.

Authors:  Benjamin Person; Marat Khaikin
Journal:  Clin Colon Rectal Surg       Date:  2007-11

6.  Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch.

Authors:  Bo Shen; Feza H Remzi; Jeffrey P Hammel; Bret A Lashner; Charles L Bevins; Ian C Lavery; Jan Wehkamp; Victor W Fazio
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

7.  Ileal pouch-anal anastomosis for Crohn's disease.

Authors:  R K Phillips
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

8.  Sphincter of Oddi dysfunction and acute pancreatitis.

Authors:  J W Chen; G T Saccone; J Toouli
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 9.  Surgery and diagnostic imaging in abdominal Crohn's disease.

Authors:  Fiorenzo Botti; Flavio Caprioli; Diego Pettinari; Alberto Carrara; Andrea Magarotto; Ettore Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-16

Review 10.  Colorectal cancer in inflammatory bowel disease: review of the evidence.

Authors:  D S Keller; A Windsor; R Cohen; M Chand
Journal:  Tech Coloproctol       Date:  2019-01-30       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.